Thank you for sharing!

Your article was successfully shared with the contacts you provided.
Arnold & Porter’s profits showed a moderate jump in 2003, continuing a path of steady growth for the firm. Gross revenue increased by nearly 7 percent, to $299 million, and profits per partner rose by 10 percent, to $825,000. The revenue expansion helped Arnold & Porter keep its seat as the second-highest-grossing firm in the District. Litigation, antitrust, and intellectual property topped the list as the strongest practice areas in 2003, says managing partner James Sandman. “Our financial performance was very good — better than 2002, which was a record year for us,” Sandman says. The firm promoted five associates to partnership in 2003. Transactional work helped keep the firm’s antitrust department busy. The firm’s antitrust attorneys represented the General Electric Co. in its landmark deal with Vivendi Universal Entertainment that created NBC Universal, a media and entertainment enterprise with expected 2005 revenue of $15 billion. Arnold & Porter had its hand in another big deal, this time as one of the firms representing French company Sanofi-Synth�labo SA in its $61.2 billion acquisition of French-German pharmaceutical giant Aventis SA. The Federal Trade Commission is scrutinizing the combination. The deal, which would create the world’s third-largest pharmaceutical company behind Pfizer and GlaxoSmithKline, has already passed muster with European Commission antitrust regulators. SBC Communications Inc. looked to the firm for antitrust and regulatory help when Cingular Wireless, a joint venture between SBC and the BellSouth Corp., acquired AT&T Wireless Services Inc. for $47 billion. The firm also reaped the rewards of a $3 billion deal that closed in 2003 by representing M&T Bank in its merger with Allfirst Financial Inc. In 2003, Arnold & Porter lawyers were national coordinating counsel for BP Amoco in litigation against manufacturers of lead paint, and for Philip Morris Inc. in tobacco litigation.The firm also serves as national coordinating counsel and trial counsel for the Wyeth Corp. in ongoing litigation regarding its diet drug mixture fen-phen. In November, an Atlanta Superior Court jury decided that Wyeth was not responsible for the health problems alleged by a nurse who had taken fen-phen, and in February a jury in a Santa Fe, N.M., district court also decided in favor of Wyeth. Not all of the firm’s results were as good. A state court jury in Beaumont, Texas, ruled that Wyeth should pay $1 billion in a case arising from lung disease that the plaintiff’s lawyers said was caused by fen-phen.

This content has been archived. It is available exclusively through our partner LexisNexis®.

To view this content, please continue to Lexis Advance®.

Not a Lexis Advance® Subscriber? Subscribe Now

Why am I seeing this?

LexisNexis® is now the exclusive third party online distributor of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® customers will be able to access and use ALM's content by subscribing to the LexisNexis® services via Lexis Advance®. This includes content from the National Law Journal®, The American Lawyer®, Law Technology News®, The New York Law Journal® and Corporate Counsel®, as well as ALM's other newspapers, directories, legal treatises, published and unpublished court opinions, and other sources of legal information.

ALM's content plays a significant role in your work and research, and now through this alliance LexisNexis® will bring you access to an even more comprehensive collection of legal content.

For questions call 1-877-256-2472 or contact us at [email protected]


ALM Legal Publication Newsletters

Sign Up Today and Never Miss Another Story.

As part of your digital membership, you can sign up for an unlimited number of a wide range of complimentary newsletters. Visit your My Account page to make your selections. Get the timely legal news and critical analysis you cannot afford to miss. Tailored just for you. In your inbox. Every day.

Copyright © 2020 ALM Media Properties, LLC. All Rights Reserved.